247 related articles for article (PubMed ID: 7000163)
1. Renin substrate, active and acid-activatable renin concentrations in human plasma and endometrium during menstrual cycles controlled by oral contraceptive preparations.
Johnson IR
Br J Obstet Gynaecol; 1980 Oct; 87(10):883-8. PubMed ID: 7000163
[TBL] [Abstract][Full Text] [Related]
2. Renin substrate, active and acid-activatable renin concentrations in human plasma and endometrium during the normal menstrual cycle.
Johnson IR
Br J Obstet Gynaecol; 1980 Oct; 87(10):875-82. PubMed ID: 7000162
[TBL] [Abstract][Full Text] [Related]
3. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
Lau TM; Witjaksono J; Affandi B; Rogers PA
Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
[TBL] [Abstract][Full Text] [Related]
4. Effects of contraceptive agents on the biochemical and protein composition of human endometrium.
Umapathysivam K; Jones WR
Contraception; 1980 Oct; 22(4):425-40. PubMed ID: 6160951
[TBL] [Abstract][Full Text] [Related]
5. Pill-a-month as an oral contraceptive.
Hefnawi F; Hassanein M; Younis N
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
[TBL] [Abstract][Full Text] [Related]
6. Active and inactive renin in pregnancy and in women on estrogen-containing oral contraceptives.
Hayashi M; Saruta T; Nakamura R; Saito I; Kondo K; Kato E
Gynecol Obstet Invest; 1979; 10(5):246-53. PubMed ID: 395034
[TBL] [Abstract][Full Text] [Related]
7. An incremental-dose combined oestrogen-progestogen oral contraceptive: cycle control and endometrial changes.
Khoo SK; McKenna H
Aust N Z J Obstet Gynaecol; 1980 Aug; 20(3):168-71. PubMed ID: 6936018
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives.
Derkx FH; Steunkel C; Schalekamp MP; Visser W; Huisveld IH; Schalekamp MA
J Clin Endocrinol Metab; 1986 Oct; 63(4):1008-15. PubMed ID: 3528208
[TBL] [Abstract][Full Text] [Related]
9. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of ethinylestradiol in blood and endometrium of women taking oral contraceptives: the sequential therapy.
Cortés-Gallegos V; Carranco A; Sojo I; Navarrette M; Cervantes C; Parra A
Fertil Steril; 1979 Nov; 32(5):524-7. PubMed ID: 499582
[TBL] [Abstract][Full Text] [Related]
11. Effect of switching with oral contraceptives.
Wassef SA; Sami G; Hamid EA
Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of pregnancy-associated endometrial alpha 2-globulin (alpha 2-PEG) during normal menstrual and combined oral contraceptive cycles and relationship to immunohistological localization.
Wood PL; Walker RA; Bell SC
Hum Reprod; 1989 Feb; 4(2):140-6. PubMed ID: 2918066
[TBL] [Abstract][Full Text] [Related]
13. The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women.
Weinberger MH; Kramer NJ; Grim CE; Petersen LP
J Clin Endocrinol Metab; 1977 Jan; 44(1):69-77. PubMed ID: 833263
[TBL] [Abstract][Full Text] [Related]
14. A direct immunoradiometric assay for human plasma prorenin: concentrations in cycling women and in women taking oral contraceptives.
Schumacher M; Nanninga A; Delfs T; Mukhopadhyay AK; Leidenberger FA
J Clin Endocrinol Metab; 1992 Aug; 75(2):617-23. PubMed ID: 1639960
[TBL] [Abstract][Full Text] [Related]
15. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[TBL] [Abstract][Full Text] [Related]
16. The renin-angiotensinogen reaction during pregnancy and oral contraception: estimation of kinetic parameters by an autologous plasma renin assay.
Daniels CR; Eisen V; Slater JD
J Endocrinol; 1987 Mar; 112(3):465-72. PubMed ID: 3549958
[TBL] [Abstract][Full Text] [Related]
17. Sequential study of plasma euglobulin fibrinolytic activity during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
Jespersen J
Gynecol Obstet Invest; 1983; 15(5):266-74. PubMed ID: 6852646
[TBL] [Abstract][Full Text] [Related]
18. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
Greene KE; Kettel LM; Yen SS
Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
[TBL] [Abstract][Full Text] [Related]
19. Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast.
Battersby S; Robertson BJ; Anderson TJ; King RJ; McPherson K
Br J Cancer; 1992 Apr; 65(4):601-7. PubMed ID: 1562470
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives--induced hypertension--nine years later.
Laragh JH
Am J Obstet Gynecol; 1976 Sep; 126(1):141-7. PubMed ID: 961741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
